1-7 of 7
Joanne Schindler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

David P. Steensma, MD, Martin Wermke, MD, Virginia M. Klimek, MD, Peter L Greenberg, MD, Patricia Font, Rami S. Komrokji, MD, Jay Yang, MD, Andrew M. Brunner, MD, Hetty E. Carraway, MD MBA, Lionel Ades, MD PhD, Aref Al-Kali, MD, Juan Manuel Alonso Dominguez, MD PhD MSc, Ana Alonso, MD, Catherine C. Coombs, MD, H. Joachim Deeg, MD, William B. Donnellan, MD, James M. Foran, MD, Guillermo Garcia-Manero, MD, Michael B. Maris, MD, Malgorzata McMasters, MD, Jean-Baptiste Micol, MD, Jaime Perez De Oteyza, MD PhD, Felicitas Thol, MD, Eunice S. Wang, MD, Justin M. Watts, MD, Silvia Buonamici, PhD, Amy Kim, MSPh PhD, Vikram Gourineni, MS, PharmD, Alyssa J Marino, Nathalie Rioux, MSc, PhD, Joanne Schindler, MD, Sherri Smith, MS, Huilan Yao, PhD, Xiaobin Yuan, Kun Yu, PhD, Uwe Platzbecker
Journal: Blood
Blood (2019) 134 (Supplement_1): 673.
https://doi.org/10.1182/blood-2019-123854
Published: 2019
Journal Articles

Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589).

Rong Lin, MD, Jing Hu, PhD, Sofia Paul, PhD, Joanne Schindler, Margaret M. Woo, Stan Spence, PhD, Samit Hirawat, MD, Harald A. Weber, MD
Journal: Blood
Blood (2009) 114 (22): 2740.
https://doi.org/10.1182/blood.V114.22.2740.2740
Published: 2009
Journal Articles

Population Pharmacokinetics of Panobinostat (LBH589) in Patients with Advanced Solid Tumors and Hematologic Malignancies Following Intravenous and Oral Administration.

Marina Savelieva, Praz, Dr., sc., math., Margaret M. Woo, Harald A. Weber, MD, Samit Hirawat, MD, Sofia Paul, PhD, Joanne Schindler, Roland Fisch, PhD
Journal: Blood
Blood (2009) 114 (22): 3780.
https://doi.org/10.1182/blood.V114.22.3780.3780
Published: 2009
Journal Articles

QT Interval Measurements in Patients with Hematologic Malignancies and Solid Tumors Treated with Oral Panobinostat (LBH589).

Harald A. Weber, MD, Feng Tai, PhD, Sofia Paul, PhD, Joanne Schindler, Margaret M. Woo, Stan Spence, PhD, Jennifer Marlowe, Rong Lin, MD
Journal: Blood
Blood (2009) 114 (22): 3781.
https://doi.org/10.1182/blood.V114.22.3781.3781
Published: 2009
Journal Articles

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Dharminder Chauhan, PhD, Yan Chang, Ph.D, Deli He, M.S, Teru Hideshima, MD, Ph.D, Klaus Podar, M.D, Florence Tao, Ph.D, Paola Neri, M.D, Robert Schlossman, M.D, Joanne Schindler, M.D, Bradley Carver, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2005) 106 (11): 4447.
https://doi.org/10.1182/blood.V106.11.4447.4447
Published: 2005
Journal Articles

Mitochondria and Caspase-Independent Cell-Death Triggered by GCS-100, a Novel Carbohydrate-Based Therapeutic in Multiple Myeloma (MM) Cells.

Dharminder Chauhan, Ph.D, Guilan Li, M.S, Klaus Podar, Ph.D, Teru Hideshima, Ph.D, Kenji Ishitsuka, M.D, Laurence Catley, M.D, Martin Sattler, Ph.D, Yu-Tzu Tai, Ph.D, Renate Burger, Ph.D, Paul Richardson, M.D, Yan Chang, Ph.D, Joanne Schindler, M.D, Bradley Carver, M.D, Kenneth C. Anderson, M.D
Journal: Blood
Blood (2004) 104 (11): 2456.
https://doi.org/10.1182/blood.V104.11.2456.2456
Published: 2004
Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD
Journal: Blood
Blood (2004) 104 (11): 3286.
https://doi.org/10.1182/blood.V104.11.3286.3286
Published: 2004